Advancing Medicines to Optimize Health Outcomes

At Gilead, we continue our legacy of making scientific breakthroughs in the pharmaceutical and medicine space.

We bring forward medicines in areas of unmet medical need through research and development and remain dedicated to developing innovative products for life-threatening illnesses that advance care for patients around the world.

The table below shows the list of GileadÔÇÖs registered pharmaceutical products in Hong Kong.

Disclaimer: The table is only for informational purpose and physician advice should be consulted.

Product Name Hong Kong Registration Number
AmBisome®
amphotericin b liposome for injection 50 mg/vial
HK-43591
Atripla®
efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg
HK-59032
Biktarvy®
bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg
HK-65914
Descovy®
emtricitabine 200 mg / tenofovir alafenamide 10 mg
emtricitabine 200 mg/ tenofovir alafenamide 25 mg
HK-64705
HK-64704
Epclusa®
sofosbuvir 400 mg/velpatasvir 100 mg
HK-65046
Genvoya®
elvitegravir 150 mg/cobicistat 150 mg/ emtricitabine 200 mg/tenofovir alafenamide 10 mg
HK-64455
Harvoni®
ledipasvir 90 mg/sofosbuvir 400 mg
HK-63886
Sovaldi®
sofosbuvir 400 mg
HK-63501
Truvada®
emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg
HK-56076
HK-57749
Veklury®
remdesivir 100 mg/vial
HK-66766
Vemlidy®
tenofovir alafenamide 25 mg
HK-65249
Viread®
tenofovir disoproxil fumarate 300 mg
HK-56075
HK-57750
Vosevi®
sofosbuvir 400 mg/velpatasvir 100 mg/voxilaprevir 100 mg
HK-65775